We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current TRVN market cap is 2.16M. The company's latest EPS is USD -46.6422 and P/E is -0.05.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 180k | -82k | 20k | 325k | 283k |
| Operating Income | -8.83M | -10.15M | -9.88M | -6.5M | -5.58M |
| Net Income | -7.93M | -16.53M | -7.69M | -4.88M | -4.94M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 31k | 3.07M | 567k | -418k | 3.13M |
| Operating Income | -26.58M | -29.49M | -51.93M | -56.38M | -35.29M |
| Net Income | -24.87M | -29.37M | -51.59M | -53.67M | -40.29M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 45.13M | 40.61M | 31.14M | 22.94M | 19.19M |
| Total Liabilities | 41.58M | 48.26M | 45.79M | 41.9M | 42.5M |
| Total Equity | 3.55M | -7.66M | -14.65M | -18.96M | -23.31M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 46.99M | 127.74M | 80.12M | 48.68M | 40.61M |
| Total Liabilities | 16.92M | 23.67M | 15.5M | 33.08M | 48.26M |
| Total Equity | 30.08M | 104.07M | 64.63M | 15.6M | -7.66M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -27.05M | -33.04M | -9.42M | -16.6M | -21.11M |
| Investing | -20k | -41k | N/A | N/A | N/A |
| Financing | 22.28M | 26.31M | -3k | -5k | 1.68M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -23.67M | -21.39M | -50.2M | -51.48M | -33.04M |
| Investing | 25.58M | 3.47M | -16k | 18k | -41k |
| Financing | -2.5M | 95.02M | 7.73M | 23.51M | 26.31M |
| Market Cap | 2.16M |
| Price to Earnings Ratio | -0.05 |
| Price to Sales Ratio | 0.69 |
| Price to Cash Ratio | 0.07 |
| Price to Book Ratio | -0.28 |
| Dividend Yield | - |
| Shares Outstanding | 863.79k |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -84.85% |
| 52 Week High | 19.2325 |
| 52 Week Low | 2.3577 |
| Spread (Intraday) | 0.03 (1.28%) |
| Company Name | Trevena Inc |
| Address |
251 little falls drive wilmington, massachusetts 19808 |
| Website | https://www.trevena.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
